In silico toxicity assessment and trace level quantification of two genotoxic impurities in silodosin using capillary gas chromatography

Author:

Panchakarla Ravi Kiran,Ravi Punna RaoORCID,Buddha Manidhar Syam Kumar,Mullangi Sumanth,Kondapalli Venkata Gowri Chandra Sekhar

Abstract

AbstractA capillary gas chromatographic method using flame ionization detection was developed and validated for the trace quantification of 2-bromoethanol (2-BE) and 2-bromoethylmethanesulfonate (2-BEM) in silodosin, used in the treatment of benign prostatic hyperplasia. Chromatographic separation was performed in spilt mode using nitrogen as carrier gas on a column containing crosslinked polyethylene glycol (30 m × 0.32 mm, 0.25 µm) stationary phase modified with nitroterephthalic acid. A simple matrix precipitation strategy was implemented to eliminate the sample overload and the matrix interference problems. The developed method was linear and accurate in the concentration range of 24–3000 ppm for 2-BE and 24–300 ppm for 2-BEM with r2 ˃ 0.999 and percent recoveries greater than 90% for both the analytes. The developed method was precise for both the analytes with RSD(%) of not more than 4.5%. In silico genotoxicity and carcinogenicity potential of 2-BEM were assessed using ICH M7 principles. The developed method can be applied in the quality control laboratories of pharmaceutical industries for trace level quantification of 2-BE and 2-BEM in silodosin.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Environmental Science,General Biochemistry, Genetics and Molecular Biology,General Materials Science,General Chemistry

Reference23 articles.

1. Elder DP, Snodin DJ. Drug substance presented as sulfonic acid salts: overview of utility, safety and regulation. J Pharm Pharmacol. 2009;61:269–78.

2. Giordani A, Kobel W, Gally HU. Overall impact of the regulatory requirements for genotoxic impurities on the drug development process. Eur J Pharm Sci. 2011;43:1–15.

3. Guorong ZHU et al. Method for synthesizing silodosin and intermediate thereof, 2018. WIPO, WO 2018/205919 A1. https://patentimages.storage.googleapis.com/03/95/7f/2b3cb399e7a248/WO2018205919A1.pdf. Accessed 30 Sept 2022.

4. International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). Guideline M7 (R1)—Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk, 2017. https://database.ich.org/sites/default/files/M7_R1_Guideline.pdf. Accessed 30 Sept 2022.

5. International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). Guideline Q2 (R2): validation of analytical procedures: text and methodology, 2022. https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf. Accessed 30 Sept 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3